SE420314B - Analogiforfarande for framstellning av indolizinderivat - Google Patents

Analogiforfarande for framstellning av indolizinderivat

Info

Publication number
SE420314B
SE420314B SE7701771A SE7701771A SE420314B SE 420314 B SE420314 B SE 420314B SE 7701771 A SE7701771 A SE 7701771A SE 7701771 A SE7701771 A SE 7701771A SE 420314 B SE420314 B SE 420314B
Authority
SE
Sweden
Prior art keywords
preparation
analogy procedure
indolizin
derivatives
indolizin derivatives
Prior art date
Application number
SE7701771A
Other languages
English (en)
Other versions
SE7701771L (sv
Inventor
J Gubin
G Rosseels
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB6680/76A external-priority patent/GB1518443A/en
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of SE7701771L publication Critical patent/SE7701771L/sv
Publication of SE420314B publication Critical patent/SE420314B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
SE7701771A 1976-02-19 1977-02-17 Analogiforfarande for framstellning av indolizinderivat SE420314B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB6680/76A GB1518443A (en) 1976-02-19 1976-02-19 Indolizine derivatives and process for preparing the same
GB3331476 1976-08-10

Publications (2)

Publication Number Publication Date
SE7701771L SE7701771L (sv) 1977-08-20
SE420314B true SE420314B (sv) 1981-09-28

Family

ID=26240878

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7701771A SE420314B (sv) 1976-02-19 1977-02-17 Analogiforfarande for framstellning av indolizinderivat

Country Status (22)

Country Link
US (1) US4103012A (sv)
JP (1) JPS52125193A (sv)
AR (2) AR211887A1 (sv)
AT (1) AT358035B (sv)
AU (1) AU505894B2 (sv)
CA (1) CA1071198A (sv)
CH (2) CH617697A5 (sv)
DE (1) DE2707048C2 (sv)
DK (1) DK142622B (sv)
ES (2) ES456039A1 (sv)
FI (1) FI61030C (sv)
FR (1) FR2341578A1 (sv)
GR (1) GR59328B (sv)
IE (1) IE44941B1 (sv)
IT (1) IT1085862B (sv)
NL (1) NL164283C (sv)
NO (1) NO145842C (sv)
NZ (1) NZ183377A (sv)
OA (1) OA05575A (sv)
PT (1) PT66199B (sv)
SE (1) SE420314B (sv)
YU (3) YU39489B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193926A (en) * 1979-07-06 1984-05-31 Labaz Sanofi Nv 2-(alkyl or phenyl)-3(4-hydroxybenzoyl)indolizines
US4378362A (en) * 1979-12-06 1983-03-29 S.A. Labaz N.V. Indolizine derivatives and process for preparing the same
FR2495616A1 (fr) * 1980-12-09 1982-06-11 Labaz Nv Nouveaux derives d'indolizine, leur procede de preparation ainsi que leurs applications en therapeutique
US4520026A (en) * 1981-02-06 1985-05-28 S. A. Labaz N.V. Indolizine derivatives and use as cardiovascular agents
FR2528845A1 (fr) * 1982-06-17 1983-12-23 Sanofi Sa Nouveaux derives d'indolizine, leur procede de preparation ainsi que les compositions therapeutiques les contenant
JPS59113802U (ja) * 1983-01-14 1984-08-01 オムロン株式会社 制御装置
FR2594438B1 (fr) * 1986-02-14 1990-01-26 Labaz Sanofi Nv Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant
US5215988A (en) * 1986-02-14 1993-06-01 Sanofi Aminoalkoxyphenyl derivatives, process of preparation and compositions containing the same
IL83821A0 (en) * 1986-09-10 1988-02-29 Sandoz Ag Azaindole and indolizine derivatives,their production and pharmaceutical compositions containing them
IL87181A (en) * 1987-08-07 1993-08-18 Sanofi Sa Aminoalkoxyphenyl derivatives, their preparation and pharmaceutical and veterinary compositions containing them
US4880824A (en) * 1987-09-21 1989-11-14 Ortho Pharmaceutical Corporation Phenyl and benzoyl substituted imidazo-fused heterocyclic calcium channel blockers
FR2642755B1 (sv) * 1989-02-07 1993-11-05 Sanofi
FR2642756B1 (fr) * 1989-02-07 1994-03-04 Sanofi Derives cycloaminoalkoxyphenyle, leur procede de preparation ainsi que les compositions pharmaceutiques ou veterinaires en contenant
FR2665444B1 (fr) * 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
FR2893616B1 (fr) * 2005-11-23 2008-01-04 Sanofi Aventis Sa Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant
FR2967412B1 (fr) 2010-11-17 2012-12-14 Sanofi Aventis Nouveaux derives d'indolizine, leur preparation et leur application en therapeutique
CN110283167A (zh) * 2018-11-14 2019-09-27 贵州省中国科学院天然产物化学重点实验室 一种抗心率失常药物布托普洛嗪的制备方法

Also Published As

Publication number Publication date
NL164283C (nl) 1980-12-15
DK142622B (da) 1980-12-01
NL7701678A (nl) 1977-08-23
NL164283B (nl) 1980-07-15
GR59328B (en) 1977-12-13
JPS52125193A (en) 1977-10-20
ES467441A1 (es) 1978-10-16
CA1071198A (en) 1980-02-05
CH617697A5 (sv) 1980-06-13
YU39489B (en) 1984-12-31
FI61030B (fi) 1982-01-29
IT1085862B (it) 1985-05-28
CH623322A5 (sv) 1981-05-29
ES456039A1 (es) 1978-05-16
FR2341578B1 (sv) 1980-04-30
DE2707048C2 (de) 1983-11-17
YU42791B (en) 1988-12-31
AR212791A1 (es) 1978-09-29
FR2341578A1 (fr) 1977-09-16
JPS5519234B2 (sv) 1980-05-24
NO770547L (no) 1977-08-22
PT66199B (pt) 1978-07-12
US4103012A (en) 1978-07-25
NZ183377A (en) 1980-04-28
YU42877A (en) 1983-01-21
YU225183A (en) 1984-10-31
IE44941L (en) 1977-08-19
AR211887A1 (es) 1978-03-31
NO145842C (no) 1982-06-09
DK72677A (sv) 1977-08-20
NO145842B (no) 1982-03-01
IE44941B1 (en) 1982-05-19
FI61030C (fi) 1982-05-10
SE7701771L (sv) 1977-08-20
ATA92077A (de) 1980-01-15
AU505894B2 (en) 1979-12-06
FI770318A (sv) 1977-08-20
DK142622C (sv) 1981-08-03
AU2239477A (en) 1978-08-24
DE2707048A1 (de) 1977-09-01
AT358035B (de) 1980-08-11
PT66199A (pt) 1977-03-01
YU42888B (en) 1988-12-31
OA05575A (fr) 1981-04-30

Similar Documents

Publication Publication Date Title
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE432595B (sv) Analogiforfarande for framstellning av piperidyl-indolderivat
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
NO821848L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
SE438856B (sv) Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat
NO772960L (no) Fremgangsmaate til fremstilling av cefalosporinderivater
SE435510B (sv) Analogiforfarande for framstellning av 3-fluor-6-piperazinylmorfantridiner
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7707407L (sv) Forfarande for framstellning av cefamderivat
NO771263L (no) Fremgangsm}te for fremstilling av indol-naftyridin-derivater
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE419083B (sv) Analogiforfarande for framstellning av nikotinoylamino-triazinderivat
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
SE427840B (sv) Analogiforfarande for framstellning av tienamycinderivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7701771-3

Effective date: 19910117

Format of ref document f/p: F